Dinalbuphine sebacate

CAT: 0804-HY-107100Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-107100Size:1 Each
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Dinalbuphine sebacate (Sebacoyldinalbuphine) is a prodrug of Nalbuphine (a κ receptor agonist and μ receptor partial antagonist) . Dinalbuphine sebacate releases Nalbuphine after hydrolysis, providing a pain relief effect lasting up to 7 days. Dinalbuphine sebacate can be used for moderate to severe postoperative pain[1][2].
CAS Number
[311768-81-7]
Product Name Alternative
Sebacoyldinalbuphine
UNSPSC
12352005
Target
Drug Metabolite
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
O[C@]12[C@@]34C5=C(C[C@@]2([H])N(CC6CCC6)CC4)C=CC(OC(CCCCCCCCC(OC7=C8C9=C(C=C7)C[C@](N(CC%10CCC%10)CC%11)([H])[C@@]%12(O)[C@]9%11[C@@]([C@H](CC%12)O)([H])O8)=O)=O)=C5O[C@@]3([H])[C@@H](O)CC1
Molecular Formula
C52H68N2O10
Molecular Weight
881.10
References & Citations
[1]Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD) : National Institute of Child Health and Human Development; 2006–. Nalbuphine. 2025 Jul 15. |[2]Tang SL, et al. Breast Milk Excretion of Dinalbuphine Sebacate Injection Administered After Cesarean Section. J Clin Pharmacol. 2024 Jun;64 (6) :755-761.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Popular Products